SCHEMBL7735192

SCHEMBL7735192

COC(=O)c1cccc(O)c1NC(=O)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
NLRP3 Q96P20 2/20 0.41
PTPN11 Q06124 1/20 0.41
GAA P10253 2/20 0.40
ANO1 Q5XXA6 2/20 0.39
POLB P06746 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
EGFR P00533 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
MAPK10 P53779 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733874 0.76 HDAC3 (0.49) LMNAGAAKMT2AKDM4ESELP
SCHEMBL6973924 0.72 KMT2A (0.47) LMNANLRP3GAAKMT2AKDM4E
SCHEMBL12548147 0.71 SMN1; SMN2 (0.55) LMNANLRP3GAAANO1KMT2A
SCHEMBL7224466 0.71 SMN1; SMN2 (0.46) LMNATSHRNLRP3KMT2AKDM4E
SCHEMBL7422995 0.71 LMNA (0.59) LMNATSHRPTPN11POLBKMT2A
SCHEMBL5242666 0.71 ATR (0.58) LMNATSHRPTPN11POLBKMT2A
SCHEMBL11914171 0.71 NAMPT (0.51) NLRP3GAAANO1KMT2A
SCHEMBL14586752 0.70 GAA (0.57) LMNATSHRGAAPOLBKMT2A
SCHEMBL7724909 0.70 NLRP3 (0.48) LMNANLRP3GAAPOLBKMT2A
SCHEMBL785309 0.70 NLRP3 (0.58) LMNATSHRNLRP3GAAANO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed